LABORATORY ARTICLES & APPLICATIONS

  • How AstraZeneca Improved Validated Workflows In GMP API Manufacturing
    How AstraZeneca Improved Validated Workflows In GMP API Manufacturing

    The reality is that paper is more of a habit than a requirement. AstraZeneca discovered this when they aimed to introduce ELNs to improve the efficiency of their validated workflows for GMP API manufacture.

  • Improving Compliance And Manufacturing Efficiency In Life Sciences
    Improving Compliance And Manufacturing Efficiency In Life Sciences

    Current market conditions such as regulations and mergers or acquisitions make improving compliance and manufacturing efficiency while driving to grow revenue and margins difficult. 

  • Revolutionizing Allergy Therapy
    Revolutionizing Allergy Therapy

    ALK-Abelló is a global research-driven pharmaceutical company that focuses on the prevention, diagnosis and treatment of allergies. Before ALK-Abelló partnered with Catalent, all marketed allergen immunotherapies were delivered by injection, resulting in a limited patient population and reduced patient adherence. Catalent worked with the client to apply Zydis Fast Dissolve Technology to their therapy. The overall result was a marked improvement in patient tolerability, preference and compliance.

  • Pulse Check: How To Assess Your In-House Biomanufacturing Capabilities
    Pulse Check: How To Assess Your In-House Biomanufacturing Capabilities

    By checking the pulse of your organization, you can identify gaps and develop a plan for how to address them, so you can make the right decisions at the right time.

  • Improved Bioavailability Of Trio Medicines TML-2 In 12 Weeks
    Improved Bioavailability Of Trio Medicines TML-2 In 12 Weeks

    Trio’s lead compound TML-2 is the acetyl prodrug of TML-1, a novel, well tolerated G-protein coupled receptor antagonist which shows clinical promise but has limited bioavailability owing to low solubility. Trio turned to Catalent for help.

  • Expediting A Promising New Therapy
    Expediting A Promising New Therapy

    An innovative biotechnology company exploring novel therapeutics for neuroscience indications had developed a promising new chemical entity for the treatment of a severe pediatric genetic disease.

  • The Importance of Proactive Clinical Returns Planning
    The Importance of Proactive Clinical Returns Planning

    Help sponsors design a more holistic strategy to their managing the clinical supply returns process.

  • Achieving Optimal mAb Titer and Quality
    Achieving Optimal mAb Titer and Quality

    In addition to having the optimal cell line and process, it is crucial to have the optimal cell culture medium and feed to maximize  performance potential.

More From Featured Laboratory Articles & Applications

LABORATORY PRODUCTS AND SERVICES

Biologics / Large Molecule Analytical Services Biologics / Large Molecule Analytical Services

Leading Analytical Scientists with Advanced Instrumentation.

Manufacturing Control Cabinets Manufacturing Control Cabinets

Control solutions for simple to medium complexity electrical and/or pneumatic systems.

An Overview of BIOVIA Environmental Health and Safety Solutions An Overview of BIOVIA Environmental Health and Safety Solutions

Organizations need to manage chemicals safely from receipt to disposal along the entire lab-to-plant value chain, ensuring Environmental Health and Safety (EH&S) compliance across the enterprise.

Whatman GD/X Syringe Filters Whatman GD/X Syringe Filters

GE’s Whatman GD/X sterile syringe filter is designed to support filtration of viscous, hard-to-filter samples with high solids content.

More Featured Products

LABORATORY NEWS

More Headlines

LABORATORY EVENTS

Digital Pathology & AI Congress: USA June 26 - 27, 2018
New York, NY
Right to Try Legislation: Impact on Industry, Health Authorities, and Patients June 28 - 28, 2018
1pm-2:30pm EDT, Online Training
Electronic Informed Consent (eIC): How The FDA/OHRP Final Guidance Affects You July 11 - 11, 2018
1pm-2:30pm EDT, Online Training
More Events